NASDAQ : CERS

Cerus Corporation — Financial statements

Healthcare · Medical Devices · United States

Last price 2.28 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 459.48M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Cerus Corporation (CERS) reported revenue of 221.55M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue221.55M206.13M180.27M156.37M162.05M130.86M
Cost of Revenue106.24M93.84M80.75M69.97M74.95M63.48M
Gross Profit115.31M112.29M99.52M86.40M87.09M67.38M
Selling, General & Admin82.26M80.91M75.89M75.52M83.33M81.29M
Research & Development61.13M67.72M58.91M67.64M64.11M63.30M
Other Operating Expenses-26.46M-27.66M-21.05M-30.43M-26.27M-28.66M
Operating Expenses116.93M120.97M113.75M112.72M121.17M115.93M
Operating Income-1.62M-8.68M-14.22M-26.32M-34.08M-48.55M
Interest Expense-7.67M-8.34M-8.88M-8.39M-5.83M-4.92M
Currency Exchange Gain (Loss)24.00K-1.27M370.00K-648.00K-690.00K-572.00K
Other Non Operating Income (Expenses)2.81M3.01M1.98M1.82M556.00K374.00K
EBT Excluding Unusual Items-6.45M-15.29M-20.75M-33.54M-40.05M-53.67M
Merger & Restructuring Charges-3.73M
Gain (Loss) on Sale of Investments5.00K6.00K-7.00K-54.00K-2.29M
Asset Writedown-387.00K
Pretax Income-6.44M-15.28M-20.76M-37.32M-42.34M-54.06M
Income Tax Expense390.00K354.00K205.00K325.00K488.00K319.00K
Earnings From Continuing Operations-6.83M-15.64M-20.96M-37.65M-42.83M-54.38M
Minority Interest in Earnings51.00K10.00K43.00K158.00K46.00K2.00K
Net Income-6.78M-15.63M-20.92M-37.49M-42.78M-54.37M
Net Income to Common-6.78M-15.63M-20.92M-37.49M-42.78M-54.37M
Shares Outstanding (Basic)194.68M190.59M184.56M180.27M176.54M171.28M
Shares Outstanding (Diluted)194.68M190.59M184.56M180.27M176.54M171.28M
EPS (Basic)-0.03-0.08-0.11-0.21-0.24-0.32
EPS (Diluted)-0.03-0.08-0.11-0.21-0.24-0.32
Free Cash Flow-1.83M1.11M8.52M-47.77M-27.61M-34.83M
Free Cash Flow Per Share-0.010.010.05-0.27-0.16-0.20
Gross Margin52.05%54.47%55.21%55.25%53.75%51.49%
Operating Margin-0.73%-4.21%-7.89%-16.84%-21.03%-37.10%
Profit Margin-3.06%-7.58%-11.60%-23.97%-26.40%-41.55%
Free Cash Flow Margin-0.83%0.54%4.73%-30.55%-17.04%-26.62%
EBITDA66.00K-7.25M-12.37M-23.73M-31.10M-45.40M
EBITDA Margin0.03%-3.52%-6.86%-15.17%-19.19%-34.69%
D&A For EBITDA1.68M1.43M1.85M2.60M2.98M3.15M
EBIT-1.62M-8.68M-14.22M-26.32M-34.08M-48.55M
EBIT Margin-0.73%-4.21%-7.89%-16.84%-21.03%-37.10%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents17.98M19.96M20.27M11.65M35.59M48.76M
Short-Term Investments38.28M62.92M60.19M54.20M66.57M80.60M
Cash & Short-Term Investments56.26M82.88M80.45M65.85M102.15M129.36M
Accounts Receivable30.98M30.77M29.78M35.50M34.53M25.13M
Receivables30.98M30.77M29.78M35.50M34.53M25.13M
Inventory65.81M56.10M38.15M39.87M29.00M26.79M
Prepaid Expenses4.26M4.63M3.64M3.22M4.46M5.82M
Total Current Assets157.31M174.38M152.02M144.44M170.14M187.10M
Property, Plant & Equipment18.33M19.33M15.54M19.35M23.48M25.18M
Long-Term Investments570.00K
Goodwill1.32M1.32M1.32M1.32M1.32M1.32M
Other Long-Term Assets28.23M26.83M32.04M32.64M23.15M23.33M
Total Assets205.19M221.86M200.92M197.75M218.09M237.50M
Accounts Payable33.52M28.01M21.70M23.84M33.00M35.61M
Accrued Expenses17.37M25.27M18.94M19.23M25.20M25.67M
Current Portion of Long-Term Debt30.09M43.34M19.30M20.00M56.16M14.70M
Current Portion of Leases3.25M2.90M2.27M2.45M2.10M1.91M
Current Unearned Revenue1.57M1.27M1.40M2.00M589.00K673.00K
Total Current Liabilities85.79M100.80M63.61M67.52M117.06M78.56M
Long-Term Debt34.83M40.55M64.86M59.80M13.64M54.72M
Long-Term Leases8.64M10.15M11.66M13.75M15.33M16.26M
Other Long-Term Liabilities5.22M5.39M3.89M3.24M3.50M2.34M
Total Liabilities134.47M156.89M144.02M144.30M149.53M151.88M
Common Stock201.00K192.00K186.00K181.00K177.00K174.00K
Additional Paid-In Capital1.16B1.15B1.12B1.10B1.08B1.05B
Retained Earnings-1.09B-1.08B-1.07B-1.04B-1.01B-964.34M
Comprehensive Income & Other-383.00K-156.00K-400.00K-1.27M-2.79M-149.00K
Total Common Equity70.02M64.22M56.15M52.65M67.61M84.62M
Minority Interest691.00K741.00K751.00K794.00K952.00K998.00K
Shareholders' Equity70.72M64.97M56.90M53.44M68.56M85.62M
Total Liabilities & Equity205.19M221.86M200.92M197.75M218.09M237.50M
Total Debt76.80M96.95M98.10M96.00M87.24M87.59M
Net Cash (Debt)-20.54M-14.07M-17.64M-30.15M14.92M41.77M
Net Cash Per Share-0.11-0.07-0.10-0.170.080.24
Filing Date Shares Outstanding201.52M192.17M185.79M181.28M177.62M173.72M
Total Common Shares Outstanding201.46M192.14M185.77M181.25M177.58M173.67M
Working Capital71.52M73.58M88.41M76.92M53.09M108.55M
Book Value Per Share0.350.330.300.290.380.49
Tangible Book Value68.71M62.91M54.83M51.33M66.29M83.30M
Tangible Book Value Per Share0.340.330.300.280.370.48
Machinery13.79M13.40M12.92M11.96M11.24M
Construction In Progress2.90M416.00K
Leasehold Improvements12.19M12.19M12.19M12.81M12.81M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-6.78M-15.63M-20.92M-37.49M-42.78M-54.37M
Depreciation & Amortization1.68M1.43M1.85M2.60M2.98M3.15M
Loss (Gain) From Sale of Assets3.00K65.00K
Asset Writedown & Restructuring Costs1.70M387.00K
Loss (Gain) From Sale of Investments-205.00K-210.00K-128.00K-116.00K1.73M-436.00K
Stock-Based Compensation20.95M22.87M22.87M20.27M24.46M23.57M
Other Operating Activities2.47M3.21M2.45M1.84M4.05M2.52M
Change in Accounts Receivable53.00K-396.00K5.50M-1.10M-9.20M-4.21M
Change in Inventory-12.89M-14.68M7.03M-14.95M-1.77M-19.61M
Change in Accounts Payable3.97M5.72M-1.48M-7.33M-4.91M12.20M
Change in Unearned Revenue-645.00K-124.00K-603.00K1.41M-84.00K96.00K
Change in Other Net Operating Assets-6.19M2.65M-5.22M-10.06M-95.00K2.79M
Operating Cash Flow2.42M4.84M11.36M-43.17M-25.61M-33.92M
Capital Expenditures-4.25M-3.73M-2.84M-4.60M-2.00M-910.00K
Investment in Securities23.09M-2.44M-5.29M13.22M10.46M13.60M
Investing Cash Flow18.84M-6.17M-8.13M8.62M8.46M12.69M
Long-Term Debt Issued5.00M9.92M212.00K21.18M
Long-Term Debt Repaid-329.00K-703.00K
Net Debt Issued (Repaid)-19.91M-329.00K4.30M9.92M212.00K21.18M
Issuance of Common Stock532.00K595.00K804.00K925.00K4.08M12.11M
Other Financing Activities-178.00K-35.00K-137.00K-175.00K-104.00K1.00M
Financing Cash Flow-19.56M231.00K4.96M10.67M4.19M34.29M
Foreign Exchange Rate Adjustments-222.00K336.00K-191.00K-128.00K-727.00K-919.00K
Net Cash Flow1.48M-761.00K8.00M-24.00M-13.69M12.14M
Free Cash Flow-1.83M1.11M8.52M-47.77M-27.61M-34.83M
Free Cash Flow Margin-0.83%0.54%4.73%-30.55%-17.04%-26.62%
Free Cash Flow Per Share-0.010.010.05-0.27-0.16-0.20
Levered Free Cash Flow875.25K2.51M11.43M-27.75M-12.91M-3.11M
Unlevered Free Cash Flow5.67M7.72M16.98M-22.50M-9.27M-29.12K
Cash Interest Paid8.52M8.52M9.29M9.21M5.10M4.18M
Cash Income Tax Paid301.00K301.00K356.00K322.00K270.00K278.00K
Change in Working Capital-15.70M-6.83M5.23M-32.03M-16.05M-8.74M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization459.48M395.70M286.00M391.39M647.59M1.17B
Enterprise Value480.01M416.12M309.13M408.15M632.16M1.14B
Last Close Price2.282.061.542.163.656.81
PS Ratio2.071.921.592.504.008.96
PB Ratio6.566.095.037.329.4513.70
P/TBV Ratio6.696.295.227.629.7714.08
P/FCF Ratio357.1333.56
P/OCF Ratio190.1081.8125.18
EV/Sales Ratio2.172.021.722.613.908.69
EV/FCF Ratio375.5636.27
Debt / Equity Ratio1.091.491.721.801.271.02
Debt / FCF Ratio87.5011.51
Net Debt / Equity Ratio0.290.220.310.56-0.22-0.49
Net Debt / EBITDA Ratio311.14-1.94-1.43-1.270.480.92
Net Debt / FCF Ratio-11.2312.702.07-0.630.541.20
Asset Turnover1.060.970.900.750.710.57
Inventory Turnover1.771.992.072.032.692.54
Quick Ratio1.021.131.731.501.171.97
Current Ratio1.831.732.392.141.452.38
Return on Equity (ROE)-10.77%-25.66%-37.99%-61.71%-55.55%-57.41%
Return on Assets (ROA)-0.48%-2.57%-4.46%-7.91%-9.35%-13.22%
Return on Capital Employed (ROCE)-1.40%-7.20%-10.40%-20.20%-33.70%-30.50%
Earnings Yield-1.53%-3.95%-7.31%-9.58%-6.61%-4.63%
FCF Yield-0.40%0.28%2.98%-12.20%-4.26%-2.97%
Buyback Yield / Dilution-3.89%-3.27%-2.38%-2.11%-3.08%-4.47%